Graves' disease and hyperthyroidism: vizsgálatok itt: Egyesült Államok
17 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- No phaseTaking peopleNatural History of Thyroid Function Disorders
- Where
- Bethesda
- Életkor
- 6 hónap to 98 év
- People
- 2500
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00001159 - 3. fázisTaking peopleStudy to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Where
- Albuquerque, Amarillo, Asheville, Atlanta, Baton Rouge, Burbank, Canton, Champaign, Chattanooga, Cincinnati, Dallas, Denton, Doral, El Paso, Farmington Hills, Fayetteville, Fort Myers, Greenville, Hialeah, Hollywood, Houston, Huntington Beach, Kansas City, La Jolla, Las Vegas, Layton, Lenexa, McKinney, Memphis, Miami, Midlothian, Morehead City, Norman, North Charleston, Oak Brook, Oakland, Orchard Park, Palm Beach Gardens, Philadelphia, Raleigh, San Antonio, San Diego, Seattle, Shavano Park, South Gate, Springfield, Statesville, St Louis, Tampa, Tucson, Walnut Creek, Washington D.C., Weslaco, Wilmington
- Életkor
- 18 év to 70 év
- People
- 300 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT07661056 · EU 2026-526455-53-00 - 2. fázisTaking peopleA Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Where
- Asheville, Dallas, Doral, Glendale, Hamilton, Hialeah, Houston, Humble, Los Angeles, Lutherville, Miami, Naperville, Richmond, San Jose
- Életkor
- 18 év to 75 év
- People
- 60 worldwide
- Run by
- Biogen
See details and how to joinNCT07722546 · EU 2026-526482-19-00 - 3. fázisTaking peopleA Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Where
- Albany, Ann Arbor, Asheville, Carlsbad, Dallas, Dearborn, El Paso, Farmington Hills, Fleming Island, Fort Lauderdale, Houston, Irving, Jacksonville, Kansas City, Kissimmee, Lenexa, McAllen, McKinney, Mesquite, Miami, New York, Orange, Pasadena, Raleigh, San Jose, Shavano Park, Wichita
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- argenx
See details and how to joinNCT07570316 · EU 2025-524223-42-00 - 2. fázisTaking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Aurora, Chapel Hill, Columbus, Concord, Dallas, Doral, El Paso, Fort Worth, Hialeah, Hickory, Houston, Irving, Jefferson City, Kansas City, Long Island City, Louisville, McKinney, Memphis, Miami, Morehead City, New Hyde Park, New York, Norfolk, Oklahoma City, Raleigh, Reno, San Antonio, St Louis, Topeka, Tucson, Williamsville
- Életkor
- 18 év to 75 év
- People
- 210 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07018323 · EU 2025-521920-31-00 - 2. fázisTaking peopleEvaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Where
- Amarillo, Bowling Green, Cary, Conroe, Dallas, Durham, Edinburg, El Paso, Flint, Fort Worth, Gilbert, Houston, Humble, La Mesa, Livonia, Macon, Miami Lakes, Niagara Falls, Ocoee, Omaha, Orchard Park, Palm Harbor, Phoenix, Sacramento, San Francisco, Sarasota, Sayre, Torrance, Tucson
- Életkor
- 18 év and over
- People
- 232 worldwide
- Run by
- Yarrow Bioscience, Inc.
See details and how to joinNCT07682896 - 1. fázisTaking peopleNEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Where
- Boston, Columbus, DeSoto, Hollywood, Miami, Morehead City, Philadelphia, Rochester, Torrance, Webster, Wesley Chapel
- Életkor
- 18 év to 65 év
- People
- 100 worldwide
- Run by
- Merida Biosciences
See details and how to joinNCT07305818 · EU 2025-523823-23-00 - 1. fázisTaking peopleEvaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye Disease
- Where
- Las Vegas, Orland Park, Wilmington
- Életkor
- 18 év and over
- People
- 72
- Run by
- Ethyreal Bio, Inc.
See details and how to joinNCT07885605 - 3. fázisTaking peopleStudy to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
- Where
- Asheville, Beverly Hills, Canoga Park, Coral Gables, East Weymouth, Glendale, Houston, Jacksonville, Las Vegas, Livonia, Morgantown, New York, Norfolk, Pasadena, Reno, San Francisco, Santa Monica, Somerset
- Életkor
- 18 év and over
- People
- 130
- Run by
- Sling Therapeutics, Inc.
See details and how to joinNCT07753603 - No phaseCsak meghívásosPressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
- Where
- Atlanta, Jacksonville, New Orleans, Sarasota
- Életkor
- 18 év to 89 év
- People
- 100
- Run by
- Sarasota Memorial Health Care System
See details and how to joinNCT06868459 - 2. fázisCsak meghívásosA Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
- Where
- Asheville, Atlanta, Aurora, Austin, Baltimore, Bellaire, Boston, Bowling Green, Canton, Chapel Hill, Chattanooga, Clearwater, Columbus, Concord, Dallas, Doral, El Paso, Englewood, Farmington Hills, Flint, Florence, Fort Worth, Gulfport, Hialeah, Hickory, Houston, Huntington Beach, Indianapolis, Irving, Jacksonville, Jefferson City, Kansas City, Las Vegas, Los Angeles, Louisville, Macon, McKinney, Memphis, Mesquite, Metairie, Miami, Monroe, Morehead City, Nashville, Newark, New Hyde Park, New Orleans, New York, Norfolk, Ocoee, Oklahoma City, Omaha, Orange, Orlando, Philadelphia, Phoenix, Port Charlotte, Portland, Pottstown, Raleigh, Reno, Rochester, Round Rock, Salt Lake City, San Antonio, Sandy City, San Francisco, Santa Clarita, Stockbridge, Summerville, Topeka, Torrance, Tucson, Washington D.C., West Palm Beach, Williamsville, Wilmington
- Életkor
- 18 év and over
- People
- 372 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07286006 - 2. fázisTaking peopleA Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Where
- Asheville, Atlanta, Austin, Baltimore, Bellaire, Boston, Bowling Green, Canton, Chattanooga, Clearwater, Dallas, Englewood, Farmington Hills, Flint, Florence, Gulfport, Houston, Huntington Beach, Indianapolis, Jacksonville, Kansas City, Las Vegas, Los Angeles, Macon, Mesquite, Metairie, Miami, Monroe, Nashville, Newark, New Orleans, Ocoee, Omaha, Orange, Orlando, Philadelphia, Phoenix, Port Charlotte, Portland, Pottstown, Rochester, Round Rock, Sacramento, Salt Lake City, San Antonio, Sandy City, San Francisco, Santa Clarita, Shreveport, Stockbridge, Summerville, Torrance, Walnut Creek, Washington D.C., West Palm Beach, Wilmington
- Életkor
- 18 év to 75 év
- People
- 240 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT06727604 · EU 2024-516020-33-00 - 4. fázisTaking peoplePreoperative Corticosteroids in Autoimmune Thyroid Disease
- Where
- Indianapolis
- Életkor
- 18 év and over
- People
- 76
- Run by
- Indiana University
See details and how to joinNCT05435547 - 1. fázisTaking peopleStudy of BHV-1300 in Graves' Disease
- Where
- Canton, Columbus, Dallas, Greenville, Houston, Memphis, Miami, Shavano Park, South Gate
- Életkor
- 18 év to 65 év
- People
- 15 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06980649 - No phaseTaking peopleTelehealth Music Therapy for Adults With Endocrine Disorder and Depression
- Where
- Boone
- Életkor
- 18 év to 65 év
- People
- 10
- Run by
- Appalachian State University
See details and how to joinNCT07413874 - No phaseTaking peopleEvaluating an AI Tool for Detecting Thyrotoxic States
- Where
- San Francisco
- Életkor
- 22 év and over
- People
- 15
- Run by
- THYROSCOPE INC.
See details and how to joinNCT07017907 - No phaseTaking peopleThe Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
- Where
- Bethesda
- Életkor
- 18 év and over
- People
- 100
- Run by
- Walter Reed National Military Medical Center
See details and how to joinNCT06275373